(Q33180080)

23 July 2017

title

Ischemic preconditioning and infarct mass: the effect of hypercholesterolemia and endothelial dysfunction (English)

1 reference

23 July 2017

0 references

0 references

O Jung

1

1 reference

23 July 2017

W Jung

2

1 reference

23 July 2017

T Malinski

3

1 reference

23 July 2017

G Wiemer

4

1 reference

23 July 2017

B A Schoelkens

5

1 reference

23 July 2017

W Linz

6

1 reference

23 July 2017

publication date

1 February 2000

1 reference

Clinical and Experimental Hypertension

23 July 2017

published in

1 reference

23 July 2017

volume

22

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

165-179

1 reference

Regulatory functions of the vascular endothelium

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

The nitric oxide hypothesis of late preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Increased resistance to ischaemic injury in the isolated perfused atherosclerotic heart of the cholesterol-fed rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Reduced endothelium-dependent relaxation at enhanced NO release in hearts of hypercholesterolaemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Nitric oxide activity in the atherosclerotic human coronary circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Beneficial effects of bradykinin on myocardial energy metabolism and infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Ischemic preconditioning: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100100070

21 January 2018

Identifiers

DOI

10.1081/CEH-100100070

1 reference

23 July 2017

1 reference